The objective of the proposed research is to elucidate the cellular mechanism by which vasopressin (VP) regulates tubular luminal membranes of mammalian kidney in health and disease. The major focus will be on elucidation of biochemical mechanism by which cyclic AMP (cAMP), generated in response to VP, regulates function of luminal plasma membranes (""""""""post cAMP steps""""""""). Studies will be conducted on two segments of tubules both regulated by VP via cAMP, but with different functional responses of luminal membranes: on collecting tubules and ducts and on ascending limb of Henle's loop. The specific objectives include: 1. To determine the localization, subcellular distribution and regulatory properties of the major enzymes and modulators of the cAMP-dependent protein phosphorylation system. We will study in particular: a) isoenzymes of cAMP-dependent protein kinases, b) protein phosphatases and c) non-enzymatic protein modulators. 2. To examine VP-regulated phosphorylations of endogenous substrates in intact tubules. Proteins and/or glycoproteins which are phosphorylated in response to increases in cAMP will be identified. Specifically, we will examine the relationship of cAMP-dependent endogenous phosphorylations to components of cytoskeleton, namely microtubules and microfilaments, calcium-calmodulin dependent proteins, and to components of luminal plasma membranes of collecting tubules and ducts. 3. To identify basic biochemical components of luminal plasma membranes of collecting tubules and ducts, we will use radiolabeled non-penetrating covalent chemical probes. Further, we will determine specific biochemical changes elicited by VP via cAMP in these membranes. 4. To study the """"""""post cAMP"""""""" components in animal models of both hyporesponsiveness and hyperresponsiveness to VP. Nephrogenic diabetes insipidus and a model of hyperresponsiveness to VP induced by administration of chlorpropamide will be studied to elucidate the pathogenesis of these dysfunctions. The studies will be conducted on renal tubules microdissected from normal rats, rabbits and mice or from animals with hereditary or drug-induced urinary concentrating defects.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK016105-16
Application #
3225521
Study Section
(SSS)
Project Start
1975-01-01
Project End
1987-12-31
Budget Start
1987-01-01
Budget End
1987-12-31
Support Year
16
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Dogan, Soner; Johannsen, Anna C; Grande, Joseph P et al. (2011) Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors. Nutr Cancer 63:389-401
Cheng, Jingfei; Zhou, Wei; Warner, Gina M et al. (2009) Temporal analysis of signaling pathways activated in a murine model of two-kidney, one-clip hypertension. Am J Physiol Renal Physiol 297:F1055-68
Rogozina, Olga P; Bonorden, Melissa J L; Grande, Joseph P et al. (2009) Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice. Cancer Prev Res (Phila Pa) 2:712-9
Diaz Encarnacion, Montserrat M; Warner, Gina M; Gray, Catherine E et al. (2008) Signaling pathways modulated by fish oil in salt-sensitive hypertension. Am J Physiol Renal Physiol 294:F1323-35
Dogan, Soner; Hu, Xin; Zhang, Yan et al. (2007) Effects of high-fat diet and/or body weight on mammary tumor leptin and apoptosis signaling pathways in MMTV-TGF-alpha mice. Breast Cancer Res 9:R91
Tracz, Michal J; Juncos, Julio P; Grande, Joseph P et al. (2007) Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol 170:1820-30
Murali, Narayana S; Ackerman, Allan W; Croatt, Anthony J et al. (2007) Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol 292:F837-44
Cheng, Jingfei; Grande, Joseph P (2007) Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease. Exp Biol Med (Maywood) 232:38-51
Cleary, Margot P; Hu, Xin; Grossmann, Michael E et al. (2007) Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response? Exp Biol Med (Maywood) 232:70-80
Cheng, Jingfei; Thompson, Michael A; Walker, Henry J et al. (2006) Lixazinone stimulates mitogenesis of Madin-Darby canine kidney cells. Exp Biol Med (Maywood) 231:288-95

Showing the most recent 10 out of 58 publications